These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5021494)

  • 41. Cellular basis of cardiac dysrhythmias.
    Williams EM
    Adv Cardiol; 1974; 12(0):256-65. PubMed ID: 4151858
    [No Abstract]   [Full Text] [Related]  

  • 42. Anesthesia and digitalis. VII. The effect of pentobarbital, halothane, and methoxyflurane on the A-V conduction and inotropic responses to ouabain.
    Morrow DH; Haley JV; Logic JR
    Anesth Analg; 1972; 51(3):430-8. PubMed ID: 5064025
    [No Abstract]   [Full Text] [Related]  

  • 43. Cardiovascular effects of bretylium tosylate in acute myocardial infarction.
    Chatterjee K; Mandel WJ; Vyden JK; Parmley WW; Forrester JS
    JAMA; 1973 Feb; 223(7):757-60. PubMed ID: 4739256
    [No Abstract]   [Full Text] [Related]  

  • 44. [New drug in the treatment of arrhythmia: bretylium toxilate].
    Jacovella G
    Clin Ter; 1970 Jul; 54(1):85-9. PubMed ID: 5481242
    [No Abstract]   [Full Text] [Related]  

  • 45. Actions of bretylium tosylate on the cardiovascular system of the dog.
    Richmond DR; Angus JA; Goodman AH; Cobbin LB
    Cardiovasc Res; 1973 Jan; 7(1):47-54. PubMed ID: 4694956
    [No Abstract]   [Full Text] [Related]  

  • 46. Influence of beta blockade and chemical sympathectomy on myocardial function and arrhythmias in acute ischaemia.
    Sethi V; Haider B; Ahmed SS; Oldewurtel HA; Regan TJ
    Cardiovasc Res; 1973 Nov; 7(6):740-7. PubMed ID: 4785547
    [No Abstract]   [Full Text] [Related]  

  • 47. Ventricular arrhythmias induced by aminophylline during halothane anaesthesia in dogs.
    Takaori M; Loehning RW
    Can Anaesth Soc J; 1967 Mar; 14(2):79-86. PubMed ID: 6034402
    [No Abstract]   [Full Text] [Related]  

  • 48. Chemical ventricular defibrillation of the human heart with bretylium tosylate.
    Sanna G; Arcidiacono R
    Am J Cardiol; 1973 Dec; 32(7):982-7. PubMed ID: 4757239
    [No Abstract]   [Full Text] [Related]  

  • 49. The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
    Mason DT; Spann JF; Zelis R; Amsterdam EA
    Clin Pharmacol Ther; 1970; 11(4):460-80. PubMed ID: 4913865
    [No Abstract]   [Full Text] [Related]  

  • 50. Control of arrhythmias following ligation of the circumflex artery.
    Armiger LC; Elswijk JG
    J Thorac Cardiovasc Surg; 1975 Jun; 69(6):891-4. PubMed ID: 166259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of ranitidine and cimetidine on experimentally induced ventricular arrhythmias in anaesthetized rats.
    Dai S
    Agents Actions; 1986 Mar; 17(5-6):460-5. PubMed ID: 3706050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bretylium in severe ventricular arrhythmias associated with digitalis intoxication.
    Vincent JL; Dufaye P; Berre J; Kahn RJ
    Am J Emerg Med; 1984 Nov; 2(6):504-6. PubMed ID: 6529463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of glucagon on ventricular arrhythmias after coronary artery occlusion and on ventricular automaticity in the dog.
    Madan BR
    Br J Pharmacol; 1971 Oct; 43(2):279-86. PubMed ID: 5158198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of bretylium toxilate in the course of myocardial infarct complicated by ventricular arrhythmia].
    Brusoni B; Cadel A; De Vita C
    Boll Soc Ital Cardiol; 1971; 16(5):211-20. PubMed ID: 4109908
    [No Abstract]   [Full Text] [Related]  

  • 56. Adrenaline-induced lignocaine-resistant dysrhythmias in experimental myocardial infarction.
    Allen JD; James RG; McNamee BT; Shanks RG; Pantridge JF
    Am Heart J; 1974 Jan; 87(1):21-5. PubMed ID: 4808755
    [No Abstract]   [Full Text] [Related]  

  • 57. Severe hypotension due to the use of bretylium for postcardiotomy ventricular arrhythmias.
    Kron IL; Nolan SP
    Ann Thorac Surg; 1983 Mar; 35(3):271-3. PubMed ID: 6600915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bretylium tosylate. A new anti-arrhythmia drug. Review].
    Arriaga Gracia J; Scampardonis G; Alexandrides K; González Hermosillo JA
    Arch Inst Cardiol Mex; 1972; 42(4):629-34. PubMed ID: 5073709
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: clinical application of a new assay for bretylium.
    Anderson JL; Patterson E; Wagner JG; Johnson TA; Lucchesi BR; Pitt B
    J Cardiovasc Pharmacol; 1981; 3(3):485-99. PubMed ID: 6168830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of ventricular dysrhythmias in the prehospital and emergency department setting.
    Mayer NM
    Am J Cardiol; 1984 Jul; 54(2):34A-36A. PubMed ID: 6464998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.